Trinity biotech receives non-compliance notice regarding nasdaq global select requirement for minimum market value of publicly held shares

Dublin, ireland, nov. 28, 2023 (globe newswire) -- trinity biotech plc (nasdaq: trib) (the “company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, today announced that on november 21, 2023 the company received notice (the “notice”) from the nasdaq stock market llc (“nasdaq”) that the company is not in compliance with the minimum market value of publicly held shares ("mvphs") requirement set forth in the nasdaq listing rules.
TRIB Ratings Summary
TRIB Quant Ranking